鲁抗医药拟竞购和成公司股权 进一步优化资源配置

Core Viewpoint - Lu Kang Pharmaceutical (600789.SH) announced its intention to acquire a 1.9231% stake in Hecheng Pharmaceutical Co., Ltd. from the Zoucheng Economic Development Zone Management Committee through a public bidding process, aiming to optimize resource allocation and improve operational decision-making efficiency [1] Group 1 - The joint venture between Lu Kang Pharmaceutical and the Zoucheng Economic Development Zone Management Committee is focused on the development of Hecheng Pharmaceutical [1] - The acquisition will result in Lu Kang Pharmaceutical holding 100% of Hecheng Pharmaceutical, although the consolidation scope of financial statements will remain unchanged [1]